Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1976-01-02
1979-07-31
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
260574, A61K 31135
Patent
active
041630637
ABSTRACT:
Smooth muscle tissue relaxation is produced in mammals by internal administration of a compound of the formula: ##STR1## wherein R is alkyl having 1 to 6 carbon atoms, the novel compound 2-N-isopropylamino-1,2,3,4-tetrahydro-5,6,-dihydroxy-naphthalene being preferred. Relief of bronchial asthma and relaxation of the uterine smooth muscle are among the therapeutic effects produced.
REFERENCES:
Cannon et al., J. of Med. Chem. (1972), vol. 15, No. 4, pp. 348-350.
W. k. Sprenger et al., J. Med. Chem. (May 1969), vol. 12, pp. 487-490.
Cannon Joseph G.
Long John P.
Friedman Stanley J.
University of Iowa Research Foundation
LandOfFree
Aminotetralin adrenergic .beta.-agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aminotetralin adrenergic .beta.-agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminotetralin adrenergic .beta.-agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-23346